Effects of Alkylating Agents on Rat Tumors
Author Information
Author(s): M. A. Presnov
Primary Institution: Institute of Experimental and Clinical Oncology, Academy of Medical Sciences of the U.S.S.R.
Hypothesis
What histological and histochemical changes occur in transplanted rat tumors after treatment with alkylating agents?
Conclusion
Alkylating agents like sarcolysine can cause significant regression in certain rat tumors, with varying effectiveness depending on the tumor type.
Supporting Evidence
- Sarcoma 45 regressed completely with sarcolysine in all treated rats.
- Sarcoma M-1 showed complete regression only with high doses of sarcolysine.
- Yoshida sarcoma regressed in 25% of cases with sarcolysine or dopan.
Takeaway
This study shows that certain medicines can make tumors in rats shrink, but they work differently on different types of tumors.
Methodology
Three types of rat tumors were transplanted into albino rats, and treated with different alkylating agents while observing histological and histochemical changes.
Limitations
The study is limited to specific types of rat tumors and may not directly translate to human cancers.
Participant Demographics
Albino rats weighing between 80 and 100 g, both male and female.
Want to read the original?
Access the complete publication on the publisher's website